ExCellThera enters into a manufacturing and collaboration agreement with New York Blood Center
May 07, 2019 08:05 ET
|
ExCellThera
MONTREAL, May 07, 2019 (GLOBE NEWSWIRE) -- ExCellThera Inc., an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for...
ExCellThera’s lead technology, ECT-001, receives FDA Regenerative Medicine Advanced Therapy (RMAT) designation
April 23, 2019 08:05 ET
|
ExCellThera
MONTREAL, April 23, 2019 (GLOBE NEWSWIRE) -- ExCellThera Inc., an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for...
ExCellThera announces clearance by FDA and Health Canada for ECT-001 in new clinical trials in United States and Canada for the treatment of leukemia
March 25, 2019 08:07 ET
|
ExCellThera
MONTREAL, March 25, 2019 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for...
ExCellThera receives FDA orphan drug designation for ECT-001 for the prevention of graft-versus-host disease
December 17, 2018 08:05 ET
|
ExCellThera
MONTREAL, Dec. 17, 2018 (GLOBE NEWSWIRE) -- ExCellThera Inc., a biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced...
ExCellThera announces results of clinical trial using ECT-001 for blood cancers
December 04, 2018 07:05 ET
|
ExCellThera
MONTREAL, Dec. 04, 2018 (GLOBE NEWSWIRE) -- ExCellThera Inc., a biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, today...
ExCellThera announces clinical trial results using ECT-001 to be presented at ASH 2018 annual meeting
November 08, 2018 07:05 ET
|
ExCellThera
MONTREAL, Nov. 08, 2018 (GLOBE NEWSWIRE) -- ExCellThera Inc., a biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, today...
Final patient receives treatment in stem cell clinical trial for severe blood cancers
June 27, 2018 08:50 ET
|
ExCellThera
MONTREAL, June 27, 2018 (GLOBE NEWSWIRE) -- ExCellThera Inc., a biotechnology company delivering molecules and bioengineering solutions to expand blood stem cells for therapeutic use, announced...